Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Assets Average (2011 - 2026)

Curis' (CRIS) quarterly Assets Average came in at $24.3 million in Q2 2026, down 29.03% on a YoY basis from $34.3 million in Q2 2025, and down 2.01% quarter-over-quarter from $24.8 million in Q1 2026.

Analysis

Curis (CRIS) Assets Average (2011 - 2026) Analysis & Trends

Curis (CRIS) has reported Assets Average for 16 consecutive years, with $24.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average fell 29.03% year-over-year to $24.3 million; the trailing twelve-month figure through Jun 2026 stood at $24.3 million (down 29.03% YoY), and the FY2025 full-year result was $30.6 million, down 48.35% from the prior year.
  • Assets Average eased to $24.3 million in Q2 2026 per CRIS's latest filing, from $24.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $151.5 million in Q1 2022 and bottomed at $23.8 million in Q4 2025.
  • Historically, Assets Average has averaged $71.1 million across 5 years, with a median of $62.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Assets Average retreated 23.27% in 2022, then tumbled 49.93% in 2024.
  • Over 5 years, Assets Average stood at $115.9 million in 2022, then decreased by 27.81% to $83.6 million in 2023, then tumbled by 49.93% to $41.9 million in 2024, then plunged by 43.15% to $23.8 million in 2025, then gained by 2.2% to $24.3 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $24.3 million, $24.8 million, and $23.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 5.34 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 30.78 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 2.09 Bn
10 Curis 2.63 Mn -2.99 Mn - 24.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.33 Mn
Mar 31, 2026 24.83 Mn
Dec 31, 2025 23.80 Mn
Sep 30, 2025 28.44 Mn
Jun 30, 2025 34.28 Mn
Mar 31, 2025 40.30 Mn
Dec 31, 2024 41.87 Mn
Sep 30, 2024 46.44 Mn
Jun 30, 2024 56.22 Mn
Mar 31, 2024 69.65 Mn
Dec 31, 2023 83.63 Mn
Sep 30, 2023 87.14 Mn
Jun 30, 2023 89.43 Mn
Mar 31, 2023 101.70 Mn
Dec 31, 2022 115.85 Mn
Sep 30, 2022 125.84 Mn
Jun 30, 2022 134.79 Mn
Mar 31, 2022 151.52 Mn
Dec 31, 2021 167.19 Mn
Sep 30, 2021 176.64 Mn